COMPARISON OF THE EFFECTS OF PARICALCITOL AND CALCITRIOL TREATMENTS ON OSTEOPROTEGERIN (OPG) LEVELS IN HEMODIALYSIS PATIENTS


ORUÇ A. , YILDIZ A. , Gul C. B. , Aktas N., Bal O., Korkmaz S., ...More

ACTA MEDICA MEDITERRANEA, vol.32, no.2, pp.325-329, 2016 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.19193/0393-6384_2016_2_48
  • Title of Journal : ACTA MEDICA MEDITERRANEA
  • Page Numbers: pp.325-329

Abstract

Introduction: Osteoprotegerin (OPG), a natural glycoprotein, which plays important roles on regulation and development of vascular calcification, is a key regulator molecule in bone turnover. Studies revealed different results about effects of vitamin D receptor activators (VDRAs) on OPG levels. This study investigated the changes in serum OPG levels and its relationships following VDRAs, paricalcitol and calcitriol treatments, in hemodialysis patients.